Purchase this article with an account.
May Shum, Elliot Crane, Jason S. Kim, Eliott Kim, David S Chu; The demographics and comorbid conditions of patients diagnosed with intermediate uveitis. Invest. Ophthalmol. Vis. Sci. 2016;57(12):4134.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To report the demographics and concurrent systemic medical conditions of subjects with intermediate uveitis.
This is a retrospective chart review. Subjects were identified with intermediate uveitis through a billing database of a tertiary care provider from April 2003 to February 2015.
45 subjects with intermediate uveitis met study criteria. 22 subjects (48.9%) were male. Age at initial visit ranged from 8-75 (mean=37, standard deviation [SD]=19) with a peak in the 5th decade of life. 36 subjects (80%) were 18 or older. 40 subjects (89%) were diagnosed with intermediate uveitis before or on their first visit. 38 subjects (84%) had bilateral intermediate uveitis, 6 (13%) with uveitis in the left eye, and 1 (2%) with uveitis in the right. Some subjects had concurrent systemic immunologic and infectious conditions, including 5 with a history of lyme disease (11%), 3 with sarcoidosis (6.6%), 3 were suspected of sarcoidosis (6.6%), 3 with rheumatoid arthritis (RA) (6.6%), and 2 with multiple sclerosis (MS) (4.4%). One subject (2%) each had syphilis, systemic lupus erythematosus, Crohn's disease, vasculitis, and fibromyalgia. 35 subjects (78%) were considered idiopathic. Other concurrent non inflammatory and non infectious conditions included 9 with hypertension (20%), 4 with diabetes mellitus (8.9%), and one (2%) each with sleep apnea, atrial fibrillation, hyperthyroidism, osteoporosis, hyperlipidemia, migraine, and myocardial infarction.
Intermediate uveitis can affect a wide range of patients. In our series, we identified rheumatoid arthritis and other immunological diseases among our patients in addition to the previously published association with sarcoidosis, Lyme and multiple sclerosis. Idiopathic cases remain to be the majority.
This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.
This PDF is available to Subscribers Only